NEW YORK (GenomeWeb News) — Beckman Coulter today said fourth-quarter revenues increased 8.6 percent as R&D spending receded 2.7 percent and profit jumped 250 percent.
Total receipts for the three months ended Dec. 31, 2006, increased to $712 million from $655.5 million year over year.
Product-related revenue increased 8.1 percent to $104 million while service-related revenue was up 8.7 percent to $608 million.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Hundreds of scientists have signed a letter criticizing the open-access Plan S, ScienceInsider reports.

A start-up company aiming to match cancer patients to treatments closes after about six weeks, Stat News reports.

NPR speaks with Rep. Eddie Bernice Johnson (D-Texas) about the US House of Representatives science committee.

In PLOS this week: somatic mutation associations unearthed in thousands of cancer exomes, pathogen detection assay, and more.